Jiangsu Nhwa Pharmaceutical Co., LTD
SZSE:002262.SZ
24.05 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 4,973.504 | 4,298.513 | 3,935.664 | 3,361.303 | 4,149.312 | 3,858.169 | 3,393.677 | 3,017.786 | 2,766.568 | 2,501.359 | 2,236.077 | 1,982.496 | 1,587.5 | 1,300.611 | 1,110.939 | 952.5 | 804.825 | 695.84 | 638.845 |
| Cost of Revenue
| 1,460.396 | 1,020.461 | 897.33 | 822.106 | 1,551.221 | 1,691.996 | 1,765.83 | 1,626.861 | 1,607.824 | 1,507.664 | 1,340.246 | 1,226.797 | 988.043 | 804.947 | 677.139 | 591.502 | 508.835 | 469.661 | 424.447 |
| Gross Profit
| 3,513.108 | 3,278.052 | 3,038.334 | 2,539.198 | 2,598.092 | 2,166.172 | 1,627.847 | 1,390.925 | 1,158.744 | 993.695 | 895.831 | 755.699 | 599.457 | 495.663 | 433.8 | 360.997 | 295.99 | 226.179 | 214.398 |
| Gross Profit Ratio
| 0.706 | 0.763 | 0.772 | 0.755 | 0.626 | 0.561 | 0.48 | 0.461 | 0.419 | 0.397 | 0.401 | 0.381 | 0.378 | 0.381 | 0.39 | 0.379 | 0.368 | 0.325 | 0.336 |
| Reseach & Development Expenses
| 515.243 | 454.252 | 351.726 | 245.863 | 188.974 | 172.025 | 111.38 | 73.198 | 54.795 | 47.641 | 46.244 | 35.059 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 51.572 | 44.187 | 43.493 | 42.778 | 50.376 | 39.325 | 37.869 | 36.06 | 33.392 | 46.581 | 106.137 | 105.022 | 83.312 | 80.597 | 78.967 | 75.047 | 73.313 | 64.164 | 61.5 |
| Selling & Marketing Expenses
| 1,737.004 | 1,654.854 | 1,594.541 | 1,309.9 | 1,469.8 | 1,193.353 | 941.259 | 815.56 | 660.328 | 557.055 | 542.719 | 455.671 | 372.645 | 309.41 | 272.065 | 215.585 | 169.809 | 132.751 | 120.089 |
| SG&A
| 1,902.749 | 1,699.041 | 1,638.034 | 1,352.677 | 1,520.177 | 1,232.678 | 979.128 | 851.62 | 693.72 | 603.636 | 648.856 | 560.693 | 455.956 | 390.007 | 351.032 | 290.633 | 243.122 | 196.915 | 181.589 |
| Other Expenses
| -25.481 | 158.951 | 126.226 | 107.952 | 145.483 | -1.699 | -0.7 | 14.466 | 7.199 | 1.836 | 2.351 | 1.832 | 2.357 | 3.256 | 0.461 | 2.21 | 5.364 | 2.192 | 3.427 |
| Operating Expenses
| 2,443.473 | 2,312.244 | 2,115.986 | 1,706.492 | 1,854.634 | 1,539.053 | 1,165.941 | 1,024.989 | 836.207 | 705.852 | 667.698 | 577.259 | 468.873 | 400.135 | 360.535 | 298.768 | 248.921 | 201.486 | 185.737 |
| Operating Income
| 1,069.635 | 1,003.465 | 925.866 | 856.135 | 770.803 | 609.895 | 445.932 | 344.258 | 293.892 | 259.474 | 203.165 | 163.901 | 118.656 | 87.056 | 62.575 | 47.616 | 33.898 | 16.135 | 14.047 |
| Operating Income Ratio
| 0.215 | 0.233 | 0.235 | 0.255 | 0.186 | 0.158 | 0.131 | 0.114 | 0.106 | 0.104 | 0.091 | 0.083 | 0.075 | 0.067 | 0.056 | 0.05 | 0.042 | 0.023 | 0.022 |
| Total Other Income Expenses Net
| 89.369 | -13.559 | -10.091 | -5.656 | -3.704 | -18.923 | -16.675 | -7.442 | -21.564 | -26.932 | -22.791 | -12.743 | -9.676 | -5.354 | -10.464 | -12.629 | -7.942 | -6.833 | -12.004 |
| Income Before Tax
| 1,159.004 | 989.907 | 915.776 | 850.479 | 767.099 | 608.196 | 445.232 | 358.494 | 300.973 | 260.911 | 205.342 | 165.698 | 120.908 | 90.174 | 62.801 | 49.6 | 39.126 | 17.86 | 16.657 |
| Income Before Tax Ratio
| 0.233 | 0.23 | 0.233 | 0.253 | 0.185 | 0.158 | 0.131 | 0.119 | 0.109 | 0.104 | 0.092 | 0.084 | 0.076 | 0.069 | 0.057 | 0.052 | 0.049 | 0.026 | 0.026 |
| Income Tax Expense
| 134.397 | 109.518 | 117.754 | 123.374 | 110.025 | 89.034 | 69.98 | 56.808 | 45.691 | 39.657 | 32.857 | 27.568 | 15.625 | 15.063 | 9.301 | 9.778 | 12.809 | 2.929 | 1.667 |
| Net Income
| 1,036.918 | 900.709 | 797.777 | 728.822 | 663.309 | 524.808 | 394.634 | 309.743 | 258.347 | 223.271 | 176.254 | 139.698 | 105.647 | 76.435 | 54.673 | 40.699 | 26.656 | 16.983 | 16.823 |
| Net Income Ratio
| 0.208 | 0.21 | 0.203 | 0.217 | 0.16 | 0.136 | 0.116 | 0.103 | 0.093 | 0.089 | 0.079 | 0.07 | 0.067 | 0.059 | 0.049 | 0.043 | 0.033 | 0.024 | 0.026 |
| EPS
| 1.03 | 0.89 | 0.79 | 0.72 | 0.66 | 0.52 | 0.39 | 0.31 | 0.26 | 0.23 | 0.18 | 0.14 | 0.12 | 0.087 | 0.063 | 0.054 | 0.041 | 0.037 | 0.045 |
| EPS Diluted
| 1.03 | 0.89 | 0.79 | 0.72 | 0.66 | 0.52 | 0.39 | 0.31 | 0.26 | 0.23 | 0.18 | 0.14 | 0.12 | 0.087 | 0.063 | 0.054 | 0.041 | 0.037 | 0.045 |
| EBITDA
| 1,244.732 | 1,162.91 | 1,099.056 | 970.95 | 901.823 | 759.591 | 536.185 | 445.515 | 384.336 | 339.312 | 271.435 | 215.065 | 163.26 | 122.84 | 96.963 | 87.092 | 70.311 | 40.746 | 41.411 |
| EBITDA Ratio
| 0.25 | 0.271 | 0.279 | 0.289 | 0.217 | 0.197 | 0.158 | 0.148 | 0.139 | 0.136 | 0.121 | 0.108 | 0.103 | 0.094 | 0.087 | 0.091 | 0.087 | 0.059 | 0.065 |